1. Russian Federation Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Zavod DIOD

Zavod DIOD

MMOEX:DIOD
7.88
RUB
-0.20
(-2.48%)
Zavod DIOD
MOEX:DIOD
(Russian Exchange)

Recent

price

7.88

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
RUB
189,025.03
17.03
16.92
16.95
12.58
12.43
14.02
10.54
9.68
8.86
8.46
7.15
5.27
6.58
6.13
- -
Revenue per Share
33,060.66
4.08
1.78
1.4
0.15
-1.71
0.63
-1.31
-1.54
-0.21
0.12
0.7
0.38
0.99
0.44
- -
Basic EPS, GAAP
-3,745.79
-0.24
-0.19
-0.07
-0.02
-0.01
- -
-0.01
-0.02
- -
-0.17
-0.02
-0.01
-0.12
-0.03
- -
Free Cash Flow per Basic Share
1,449.4
0.27
0.11
0.59
0.25
0.12
0.27
0.12
- -
0.4
0.36
0.42
0.4
0.59
0.77
- -
Dividend per Share
14.95
18.68
19.93
20.23
19.88
17.73
18.36
17
13.74
13.09
12.91
13.25
13.21
13.51
13.18
18.36
Book Value per Share
6.82
3.72
4.35
4.6
11.8
9.78
9.18
11.54
11.81
11.04
11.59
11.99
11.11
11.42
11.03
9.18
Tangible Book Value per Share
- -
92
92
92
92
92
92
92
92
91
92
92
98
92
92
- -
Basic Weighted Avg Shares
1,730
1,559
1,548
1,551
1,151
1,137
1,283
964
886
802
774
658
517
602
561
96
Sales/Revenue/Turnover
26.42
18.42
19.55
17.61
13.77
15.81
14.62
8.72
9.96
-5.57
12.64
11.02
14.61
15.13
9.3
15.04
Operating Margin (%)
- -
- -
- -
11
5
4
10
7
5
9
15
5
10
6
5
- -
Depreciation Expense
303
374
163
128
14
-157
57
-120
-141
-19
11
64
37
91
40
100
Net Income, GAAP
25.9
11.19
21.48
25.2
68.41
- -
28.1
- -
- -
- -
78.11
19.23
38.97
22.77
29.4
- -
Effective Tax Rate (%)
17.49
23.97
10.5
8.24
1.18
-13.78
4.46
-12.45
-15.9
-2.38
1.42
9.79
7.21
15.07
7.2
103.62
Profit Margin (%)
661
523
934
1,094
1,320
978
602
790
834
736
735
755
815
835
809
602
Working Capital
310
76
381
460
711
340
7
7
7
7
7
- -
- -
- -
- -
7
LT Debt
1,425
2,005
2,174
2,310
1,807
1,609
1,667
1,546
1,246
1,196
1,178
1,209
1,202
1,228
1,200
1,667
Total Equity
- -
11.06
8.74
6.86
1.71
- -
5.87
- -
- -
- -
1.73
4.74
3.8
5.78
3.04
- -
Return on Invested Capital (%)
- -
21.73
10.11
7.2
1.73
- -
5.45
- -
- -
- -
1.24
5.38
3.3
7.65
3.17
- -
Return on Capital (%)
- -
24.29
9.2
6.95
0.74
-9.11
3.46
-7.42
-10.02
-1.56
0.92
5.38
3.08
7.42
3.31
6.05
Return on Common Equity (%)

Capital Structure

RUB

•

in mil. unless spec.
Jun'14
Sep'14
Dec'14
ST Debt
520
50
446
LT Borrowings
105
240
7
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
92
92
92
Market Capitalization
387
388
309

Working Capital

RUB

•

in mil. unless spec.
Jun'14
Sep'14
Dec'14
Total Current Assets
1,423
1,410
1,334
Cash, Cash Equivalents & STI
15
15
2
Accounts Receivable, Net
463
671
316
Inventories
605
602
751
Total Current Liabilities
756
309
732
Payables & Accruals
- -
- -
- -
ST Debt
520
50
446
Deferred Revenue
- -
- -
- -

Growth Rates

RUB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3.76%
0.09%
-2.29%
Free Cash Flow
- -
- -
-74.29%
Net Income, GAAP
-139.8%
74.99%
-55.48%
Sales/Revenue/Turnover
-6.1%
-6.03%
-6.8%
Total Cash Common Dividend
18,057.92%
15.5%
29.57%

Semi-annual Revenue

RUB

•

in mil. unless spec.

Year

H1
H2
FY
2021
- -
- -
602
2022
- -
- -
561
2023
- -
- -
- -

Semi-annual Earnings Per Share

RUB

•

in mil. unless spec.

Year

H1
H2
FY
2021
- -
- -
0.99
2022
- -
- -
0.44
2023
- -
- -
- -

Semi-annual Dividends Per Share

RUB

•

in mil. unless spec.

Year

H1
H2
FY
2021
- -
- -
0.59
2022
- -
- -
0.77
2023
- -
- -
- -
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
DIOD Maker of Eco-Friendly Equipment and Nutrition Public Joint Stock Company engages in the research, development, manufacture, and sale of biologically active food additives, pharmaceuticals, medical active cosmetics for home use, and eco-friendly medical equipment. Its product portfolio includes dietary supplements under brand names such as Capilar, Viardo, Viardo Forte, Arthro-Active, Stella, Longevity, Cardio Capilar, Oculist, Capital, Iodine-Active, Calcium-Active Citrate, and Selenium-Active. The company also produces pharmaceutical preparations, healing cosmetics, and medical environmental technology products including silver water purifiers and light therapy apparatus. The company operates through subsidiaries and affiliated companies and offers its products mainly in Russia and neighboring countries including Belarus, Ukraine, Kazakhstan, Georgia, Armenia, Serbia, Montenegro, Moldova, Latvia, the Czech Republic, and Bulgaria. It markets its products through wholesalers and foreign partners targeting consumer healthcare and pharmaceutical sectors with a focus on natural raw materials and sustainable health solutions. Founded in 1931 and headquartered in Moscow, Russia, DIOD has recently reported improved financial results for the first half of 2025, with sales increasing to RUB 267.04 million and net income turning positive to RUB 3.42 million compared to previous losses. The company continues to expand its product range and markets while maintaining a commitment to environmentally responsible business practices and innovation in eco-friendly medical equipment and nutrition products. Recent strategic developments include enhanced focus on natural ingredient-based medicines and expansions in the biologically active additives segment, strengthening distribution channels in CIS and Eastern European markets. DIOD also continues investment in healthcare services through its medical center Mir ekologii, complementing its product offering with healthcare provision. This reflects the company’s integrated approach to eco-friendly equipment and nutrition solutions in the pharmaceutical and consumer health industry.